Search research articles
Contact Us
Filters
Showing results (261-270 of 293) with videos related to
Page
of 30
Sort By:
British Journal of Cancer
|
February 8, 2007
Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells
A M E Bruynzeel, M A Abou El Hassan, E Torun, et al.
Blood
|
May 1, 1996
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma
D D Weisenburger, B G Gordon, J M Vose, et al.
Cancer Gene Therapy
|
April 8, 2003
The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells
M A I Abou El Hassan, M Heijn, M J W E Rabelink, et al.
Current Opinion in Cardiology
|
April 30, 2025
Hypertension in atherosclerotic cardiovascular disease: insights into epidemiology, management strategies, and outcomes
Prerna Gupta, Julia A Bast, Alexander C Razavi, et al.
Food & Function
|
July 5, 2021
Gastrointestinal digestion of dietary advanced glycation endproducts increases their pro-inflammatory potential
T van der Lugt, M F Vrolijk, T F H Bovee, et al.
The Journal of Antimicrobial Chemotherapy
|
August 8, 2012
High prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, Germany
A Kola, C Kohler, Y Pfeifer, et al.
The European Respiratory Journal
|
October 12, 2000
Inhibition of nitric oxide synthase by nasal decongestants
G J Westerveld, H P Voss, R M van der Hee, et al.
British Journal of Cancer
|
February 28, 2007
Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice
A M E Bruynzeel, M A Abou El Hassan, C Schalkwijk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin
S A van Acker, E Boven, K Kuiper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1995
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma
D A Stewart, J M Vose, D D Weisenburger, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 293) with videos related to
Sort By:
Page
of 30
British Journal of Cancer
|
February 8, 2007
Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells
A M E Bruynzeel, M A Abou El Hassan, E Torun, et al.
Blood
|
May 1, 1996
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma
D D Weisenburger, B G Gordon, J M Vose, et al.
Cancer Gene Therapy
|
April 8, 2003
The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells
M A I Abou El Hassan, M Heijn, M J W E Rabelink, et al.
Current Opinion in Cardiology
|
April 30, 2025
Hypertension in atherosclerotic cardiovascular disease: insights into epidemiology, management strategies, and outcomes
Prerna Gupta, Julia A Bast, Alexander C Razavi, et al.
Food & Function
|
July 5, 2021
Gastrointestinal digestion of dietary advanced glycation endproducts increases their pro-inflammatory potential
T van der Lugt, M F Vrolijk, T F H Bovee, et al.
The Journal of Antimicrobial Chemotherapy
|
August 8, 2012
High prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, Germany
A Kola, C Kohler, Y Pfeifer, et al.
The European Respiratory Journal
|
October 12, 2000
Inhibition of nitric oxide synthase by nasal decongestants
G J Westerveld, H P Voss, R M van der Hee, et al.
British Journal of Cancer
|
February 28, 2007
Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice
A M E Bruynzeel, M A Abou El Hassan, C Schalkwijk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin
S A van Acker, E Boven, K Kuiper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1995
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma
D A Stewart, J M Vose, D D Weisenburger, et al.
Page
of 30